Earnings Winners & Losers: BSX, BCR, EW, PHG, SYK, TFX, TMO
Executive Summary
The earnings season is now in full swing with more large-cap medtech stocks releasing their quarterly results. This week we spotlight cardiology market leaders Boston Scientific and Edwards Lifesciences, big ortho hitter Stryker, specialty diagnostics provider Thermo Fisher, and diversified players such as Philips, Bard and Teleflex. But which among them are this season's earnings winners and losers?
You may also be interested in...
Teleflex Buys Vascular Solutions For $1bn To Improve Growth
The purchase price of $56 a share in cash is a modest 16% premium over Vascular Solutions' 90-day average price. Vascular Solutions' CEO says uncertainty about the future leadership of the company compelled it to consider acquisition offers.
Earnings Winners & Losers: QGEN, WMGI, ALR, SN, and LIVN
Diagnostics, orthopedics, and cardiovascular device companies are among those that wait until November to report their results for the quarter that ended at the end of September. Medtech Insight’s Earnings Winners & Losers highlights some of the companies that had news to celebrate, and a few that were disappointed with the quarter.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.